Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains-Reference-Cited by-同舟云学术

Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains

Published:2010-02 Issue:2 Volume:51 Page:334-344
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Abate Wondwossen,Alghaithy Abdulaziz A.,Parton Joan,Jones Kenneth P.,Jackson Simon K.

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference69 articles.

1. CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium;Becker;J. Biol. Chem.,2000

2. The innate immune response of the respiratory epithelium;Diamond;Immunol. Rev.,2000

3. Differences in LPS-induced activation of bronchial epithelial cells (BEAS-2B) and type II-like pneumocytes (A549);Schulz;Scand. J. Immunol.,2002

4. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin;Skerrett;Am. J. Physiol. Lung Cell. Mol. Physiol.,2004

5. Alveolar epithelial type II cell: defender of the alveolus revisited;Fehrenbach;Respir. Res.,2001

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Lipopolysaccharides in the Inflammation and Pyroptosis of Alveolar Epithelial Cells in Acute Lung Injury and Acute Respiratory Distress Syndrome;Journal of Inflammation Research;2024-08

2. Modified Sanliangsan Improved Sjogren’s Syndrome Complicated with Interstitial Lung Disease by Suppressing Serum MUC1 Levels;ACS Omega;2024-07-05

3. Modified Sanliangsan improved Sjogren’s syndrome complicated with interstitial lung disease by suppressing serum MUC1 levels;2024-04-26

4. Dietary Chito-oligosaccharide attenuates LPS-challenged intestinal inflammation via regulating mitochondrial apoptotic and MAPK signaling pathway;International Immunopharmacology;2024-01

5. Development of a physiomimetic model of acute respiratory distress syndrome by using ECM hydrogels and organ-on-a-chip devices;Frontiers in Pharmacology;2022-09-02